Kintor Pharmaceutical Limited (HKG:9939)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.220
-0.020 (-1.61%)
May 16, 2025, 4:08 PM HKT
1.67%
Market Cap 529.72M
Revenue (ttm) 5.32M
Net Income (ttm) -165.26M
Shares Out 434.20M
EPS (ttm) -0.38
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 720,000
Average Volume 1,270,375
Open 1.200
Previous Close 1.240
Day's Range 1.200 - 1.250
52-Week Range 0.790 - 1.840
Beta -0.12
RSI 49.19
Earnings Date May 26, 2025

About Kintor Pharmaceutical

Kintor Pharmaceutical Limited, a clinical-stage biotechnology company, engages in researching, developing, and commercializing therapeutic drugs for dermatology and tumors indications with the unmet medical needs in the People’s Republic of China. Its product candidates include KX-826, a potential topical drug for the treatment of androgenic alopecia and acne vulgaris; and Pruxelutamide (GT0918), a second-generation androgen receptor (AR) for the treatment of metastatic castration-resistant prostate cancer, COVID-19, and AR+ metastatic breast c... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2009
Employees 168
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 9939
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements

News

There is no news available yet.